Yuan Dong-Sheng, Chen Yan-Ping, Tan Li-Li, Huang Shui-Qing, Li Chang-Qing, Wang Qi, Zeng Qing-Ping
Clinical Pharmacology Institute, Guangzhou University of Chinese Medicine, Guangzhou, China.
Tropical Medicine Institute, Guangzhou University of Chinese Medicine, Guangzhou, China.
Front Pharmacol. 2017 Oct 17;8:737. doi: 10.3389/fphar.2017.00737. eCollection 2017.
Although artemisinin has been used as anti-malarial drug, accumulating evidence on the extended therapeutic potential of artemisinin emerges. Apart from anti-malaria and anti-tumor, artemisinin can also exert beneficial effects on some metabolic disorders, such as obesity, diabetes, and aging-related diseases. However, whether artemisinin should be applied to treatment of the wide-spectrum diseases is debating. Here, we discuss the predisposition of a raised risk of malarial resistance to artemisinin from consideration of the multi-target and non-specific features of artemisinin.
尽管青蒿素已被用作抗疟药物,但关于青蒿素具有广泛治疗潜力的证据越来越多。除了抗疟疾和抗肿瘤作用外,青蒿素对一些代谢紊乱,如肥胖、糖尿病和衰老相关疾病也有有益作用。然而,青蒿素是否应应用于治疗这些广谱疾病仍存在争议。在此,我们从青蒿素的多靶点和非特异性特征出发,讨论疟疾对青蒿素产生耐药性风险增加的易感性。